Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
about
GABA System in Schizophrenia and Mood Disorders: A Mini Review on Third-Generation Imaging StudiesA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesHigh-frequency oscillations and the neurobiology of schizophreniaGABA abnormalities in schizophrenia: a methodological review of in vivo studiesMetabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studiesMaternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons.In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophreniaMolecular substrates of schizophrenia: homeostatic signaling to connectivityMice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalonIn vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T.Altered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration.Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update.Relationship between Glutamate Dysfunction and Symptoms and Cognitive Function in Psychosis.Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.[Neurobiology of schizophrenia: new findings from the structure to the molecules].Glutamate-mediated excitotoxicity in schizophrenia: a review.Hippocampal and thalamic neuronal metabolism in a putative rat model of schizophrenia.Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiationIn vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia.Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra.Neurobiological background of negative symptoms.In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of conceptCortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.Fully automated macromolecule suppressed single voxel glutamate spectroscopy (FAMOUS SVGS).Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS StudiesBrain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature.Brain gamma-aminobutyric acid (GABA) abnormalities in bipolar disorderImaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopyReduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopyGABA and glutamate in schizophrenia: a 7 T ¹H-MRS study.Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.GABAergic contributions to alcohol responsivity during adolescence: insights from preclinical and clinical studiesGlutamatergic neurometabolites in clozapine-responsive and -resistant schizophreniaAlterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammationEffects of chronic inhibition of GABA synthesis on attention and impulse control.Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia
P2860
Q26752657-5963D03D-C80B-4189-B8D6-1F47581D8ED4Q26786354-D3D52E7D-893D-4A8A-93F0-C8B6473C5776Q26829587-15961D24-83D0-4477-A234-BC1ADE8A3E43Q26864125-CDBAAB5A-6206-4BA0-99C6-E0682631637AQ26865740-C4C9AE27-0D14-4DAF-8C9F-E53BE5DEF6DDQ27319478-026067FD-2F2B-448E-AD5C-4D8F3982F87BQ28083121-2BAD7976-F199-4073-AB4C-FD69D9006B5BQ30383611-9037082D-A69E-4EFF-AAB7-4DFCBB4D6336Q30404423-FFCD8602-FFF9-487F-8A54-71E6B0D5AD40Q30413276-45A35549-5360-401E-AAD6-6885C1FBC028Q30647676-98AC0AB4-46AB-4617-9D4E-B3D91D8CA591Q30685335-21BDB5B3-9AEC-4B57-951A-526A398DD1BCQ30686416-BF3C8791-7859-4663-8B54-4BE00CE1DE16Q30712278-8D40852F-CB36-41E4-80E8-7595F6318759Q30732395-6062BB4D-233C-4C7A-B1A9-C6659656AC01Q30842754-687F6CE3-6494-4F89-9B03-B23E4DE90C0CQ30845062-8CE9726A-F430-4292-A3CC-BACAF94E5BE6Q30849611-3FA308D9-B51E-49EA-9258-1100F3C88109Q30854782-2CEA33D2-D76B-47B8-B845-4C8689CD6C3EQ30873588-6145F8B2-5124-4FB7-B3A1-FE6893A4979CQ30882229-0F1B1487-DCDC-45E8-8B9E-C5F8FFB7B78DQ30913824-17FF6735-428C-4D23-B888-0A9235AC1AE9Q30976220-3607A227-E8BA-454B-97A3-01B5B9501F9EQ30993265-C0B42868-47E0-419B-A260-3429602BB25CQ31090438-31800090-8DF0-4B16-9444-F57C03615B5FQ31108616-DA36BB93-870C-4C71-92A8-0E25ADBFC258Q31117451-6AA7253C-7B89-4054-AE9E-2BA228BF7E78Q33611412-75ABE87C-9F8A-49D2-BB33-0427DC2A896EQ33718818-A4AC7365-4AA2-4054-AC34-0E571068CEC3Q33893005-039D6BDC-9DBE-4BE0-9A32-4712E942ED9AQ33930038-FEFABC22-6490-4E05-AD42-C67794B62C5FQ34048560-D358616B-1BAE-4DE8-8660-B1735ED25202Q34360615-E7814FC6-E413-4D9A-AD3B-49F145B227ADQ34446463-EF156D2A-4E52-4487-97DF-9A83D5107F0CQ35002529-0DA4C6D4-4C63-4912-9ABA-A83A80119B71Q35121218-3C7C9722-5694-4662-A80E-B0F2C0BDE5A4Q35626964-55173724-A481-44D2-BB0C-8855B07D8604Q35715200-5488AB99-D388-4EC3-9018-5C23C615301EQ35822731-E216B12E-611B-482B-A9D4-2A3302E88108Q35872055-EBF88040-88AB-4ADB-B000-839D87200D15
P2860
Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@ast
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@en
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@nl
type
label
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@ast
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@en
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@nl
prefLabel
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@ast
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@en
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@nl
P2093
P50
P1433
P1476
Elevated prefrontal cortex γ-a ...... gnetic resonance spectroscopy.
@en
P2093
Arielle D Stanford
Lawrence S Kegeles
Mark Slifstein
Najate Ojeil
Ragy Girgis
Roberto Gil
Xiangling Mao
Xiaoyan Xu
P304
P356
10.1001/ARCHGENPSYCHIATRY.2011.1519
P407
P577
2012-01-02T00:00:00Z